ArticleJournal of bone oncology2022

Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.

Andreas Jakob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.